Philips aims to transform diagnostic cardiology with introduction of new Cardiac Workstation

Launching in EMEA, Philips Cardiac Workstation uses sophisticated algorithms to speed collection and processing of ECG data, helping streamline care and prioritize at-risk patients

Jun 11, 2024 | 3 minute read

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) a global leader in health technology, has introduced Cardiac Workstation, a groundbreaking new cardiac care platform designed to accelerate clinical decision-making and care for cardiology patients, in Europe, Middle East and Africa [1]. The Cardiac Workstation uses advanced algorithms to access, analyze, and manage electrocardiograph (ECG) data either remotely or at the point of care. This new technology builds on the cardiograph of the past to help improve diagnostic cardiology by streamlining data collection and reducing administrative workload – allowing care teams to spend more time on direct patient care.

Clinicians review ECG data on Philips Cardiac Workstation

“A common theme I hear from care providers and hospital administrators is that they seek ways to alleviate their care teams’ workload without sacrificing the quality of patient care. To achieve that, they need access to the right information at the right time, wherever their point of decision may be,” said Stefano Folli, Business Leader, Ambulatory Monitoring & Diagnostics, Philips. “That’s the beauty of Philips Cardiac Workstation. It helps streamline workflow using advanced algorithms to access and analyze ECG from anywhere, paving the way to more efficient and effective patient care by enabling clinicians to quickly identify and prioritize the most at-risk patients.”

That’s the beauty of Philips Cardiac Workstation. It helps streamline workflow using advanced algorithms to access and analyze ECG from anywhere, paving the way to more efficient and effective patient care by enabling clinicians to quickly identify and prioritize the most at-risk patients.

- Stefano Folli, Business Leader, Ambulatory Monitoring & Diagnostics, Philips

Heart disease remains the leading cause of death globally [2]. Challenges and costs of managing cardiac conditions continue to grow while staff shortages, retention challenges, and expanded training requirements remain imminent. Administrators and clinicians face increasing pressure to efficiently care for this growing population of cardiac patients across a variety of care settings, which requires an end-to-end, broader ecosystem approach. The Cardiac Workstation helps to address these challenges by:

Enhancing Workflow – Gesture-driven interactions like zoom, scroll and swipe functions allow care providers to review and interpret ECGs with the same familiarity as if they were using a smartphone. A simple interface with a three-step workflow also helps clinicians minimize data entry errors and quickly capture, analyze and export accurate ECGs.
Providing Clinical Decision Support – The ability to access and view accurate demographic information and deep clinical data around the patient – such as zooming in on views of irregular rhythms or scrolling through multiple ECGs to identify trends – support clinicians in making confident and timely care decisions. When used in tandem with Philips IntelliSpace ECG management system, clinicians can also view side-by-side comparisons of current and previous ECGs to identify trends and risks.
Enabling Enterprise Interoperability – Designed to be part of a broader ecosystem, Cardiac Workstation can interoperate with multiple enterprise systems beyond IntelliSpace ECG or your current departmental systems. Seamless integration with existing electronic medical record (EMR) and system technology allows ECG data to be easily accessed and shared throughout the enterprise. This holistic view of patient data enables care to take place in the most cost-and-clinically-effective setting, while ensuring informed diagnoses and interventions.

Philips’ flexible diagnostic, screening and enterprise ECG management solutions advance a new standard of cardiac care, giving healthcare organizations the power to deliver better diagnostics by enabling intervention and treatment in the right setting, at the right time. When leveraging the full strength of the Philips ECG portfolio, care providers can strategically manage the patient population through new, accessible care models informed by healthcare data and actionable insights.

Sources

[1] Not available in all markets. Pending 510(k). Not available for sale in the U.S.A.
[2] World health statistics 2024: monitoring health for the SDGs, Sustainable Development Goals. World Health Organization. 2024.

About Royal Philips

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.

Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,100 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.